Facilitating Tobacco Treatment in Veterans with Serious Mental Illness
Official title: External Facilitation to Expand Reach of Tobacco Treatment to SMI Veterans
Run by VA Office of Research and Development · NCT07455526 · Data updated 2026-11-12
This project tests an external facilitation approach to help VA clinics prescribe smoking medications more often to Veterans with serious mental illness who smoke.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 65 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | August 3, 2026 |
| Main results expected | January 31, 2030 |
| Study ends | May 1, 2031 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07455526 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Providers and Veterans within VA Maryland Health Care System clinics serving this population who have a recent tobacco use screen and an upcoming psychiatric appointment.
✕Probably not a fit
Patients who are not engaged with VA mental health services or who do not smoke may not benefit from this implementation effort.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program uses a multi-component facilitation strategy to implement evidence-based tobacco treatment in VA mental health settings. It targets providers and patients within the VA Maryland Health Care System, aiming to increase the rate of tobacco medication prescribing alongside brief behavioral counseling. The approach includes activities like academic detailing and auditing with feedback, tailored to local clinic needs, to overcome barriers to care. The study analyzes how external facilitation affects the integration of recommended tobacco treatments into routine practice for SMI Veterans who smoke.
Why it matters
Potential benefit: If successful, more Veterans with serious mental illness could receive effective tobacco medications and counseling, potentially improving quit rates and reducing smoking-related health risks.
How similar studies have gone: Prior implementation efforts using external facilitation have shown promise in increasing evidence-based tobacco treatment delivery in healthcare settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Providers: * VA Maryland Health Care System patient care providers serving Veterans in Critical Time Intervention, Psychosocial Rehabilitation and Recovery Center, Mental Health Integrative Case Management, or outpatient psychiatry clinics Veterans receiving direct letters: * Had an appointment in VA Maryland Health Care System, Critical Time Intervention, Psychosocial Rehabilitation and Recovery Center, Mental Health Integrative Case Management, or outpatient psychiatry clinics in the last 30 days * Diagnosed with a serious mental illness * Positive tobacco use screen * Appointment scheduled with an outpatient psychiatric prescriber in the next 30 days * Of note, study staff are not directly recruiting Veterans for this implementation intervention component Veteran chart review: * All Veterans actively enrolled in VAMHCS medical facilities with at least one encounter during a given period with available smoking health factor data * Of note, study staff are not directly recruiting Veterans for this data analysis Exclusion Criteria: Providers: * None Veterans receiving direct letters: * Active prescription for bupropion, varenicline, or any nicotine replacement therapy
Where it's running
-
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Corinne N Kacmarek, PhD — Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
- Study coordinator: Corinne N Kacmarek, PhD
- Email: corinne.kacmarek2@va.gov
- Phone: (410) 340-0727
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized brain-targeted TMS for smoking cessation
A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.
-
BRIDGE NET: virtual collaborative care for patients with serious mental illness and new cancer
A virtual, team-based care program tests whether BRIDGE NET can improve care for adults with serious mental illness who are newly diagnosed with cancer.
-
Multilevel program to increase LDCT lung cancer screening and help African American smokers quit
This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.
-
TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping
This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.
-
Impact of Menthol vs. Non-Menthol Cigarettes on Abuse Liability
This study tests whether menthol cigarettes have different abuse potential than non-menthol cigarettes in menthol cigarette users, using a within-subject design across lab sessions and daily diaries.
-
Engaging Latinos with Serious Mental Illness Using Culturally Responsive Peer Support
This pilot tests whether culturally tailored, peer-delivered motivational interviewing can help Latinos with serious mental illness start or restart mental health care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.